September 2008 Oncology News International

Publication
Article

Cover Story

The surgeon who challenged the breast ca paradigm

Payer's budget to get right targeted drug to right patient

New paradigm in pancreatic cancer promotes coordinated patient care

DEPARTMENTS

Focus on Breast Cancer

In elderly with early breast ca, stick with standard chemo

Herceptin erases survival difference between HER2- patients

Focus on Colon Cancer

Adding oxaliplatin to FULV trends toward better survival in stage II/III colon cancer

News & Analysis

Reimbursement for new RT lags behind implementation

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Historical standards for H3 K27M-mutant diffuse midline glioma treatment may harm healthy central nervous system cells, according to Ashley L. Sumrall, MD.